Overview

TRAnexamic Acid for Preventing Postpartum Hemorrhage Following a Cesarean Delivery

Status:
Completed
Trial end date:
2020-04-08
Target enrollment:
Participant gender:
Summary
The aim is to assess the impact of tranexamic acid (TXA) for preventing postpartum hemorrhage (PPH) following a cesarean section (CS).
Phase:
Phase 3
Details
Lead Sponsor:
University Hospital, Bordeaux
Collaborator:
Ministry of Health, France
Treatments:
Pharmaceutical Solutions
Tranexamic Acid